BrainSight
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | $80.0k | Seed |
$750k | Seed | ||
N/A | - | ||
* | $120k | Convertible | |
Total Funding | CAD1.3m |
Related Content
Recent News about BrainSight
EditBrainSightAI is an innovative startup focused on revolutionizing the field of neuroscience through advanced technology. The company specializes in developing cutting-edge tools for brain imaging and analysis, aiming to enhance the diagnosis and treatment of neurological conditions. Their flagship product, VoxelBox, leverages artificial intelligence (AI) to provide detailed brain maps using resting-state functional MRI (rs-fMRI). This technology allows for precise surgical planning and better understanding of brain functions without requiring patients to perform tasks during imaging.
BrainSightAI primarily serves medical professionals, including neurosurgeons, psychiatrists, and neurologists, who are looking for technology-driven solutions to improve patient outcomes. The company operates in the healthcare and medical technology market, focusing on the intersection of neuroscience and AI.
The business model of BrainSightAI is based on providing software-as-a-service (SaaS) solutions to healthcare providers. They generate revenue through subscription fees for their VoxelBox platform, which offers continuous updates and support. Additionally, they may engage in partnerships and collaborations with research institutions and healthcare organizations to further advance their technology and expand their market reach.
In summary, BrainSightAI is at the forefront of integrating AI with neuroscience to offer innovative solutions that improve the accuracy of brain imaging and treatment planning. Their focus on non-invasive, data-driven approaches helps medical professionals make better-informed decisions, ultimately enhancing patient care.
Keywords: neuroscience, AI, brain imaging, VoxelBox, rs-fMRI, healthcare, neurology, SaaS, surgical planning, medical technology.